Antiphospholipid and antiprotein syndromes in non-thrombotic, non-autoimmune women with unexplained recurrent primary early foetal loss. The Nimes obstetricians and Haematologists Study - NOHA

Thrombosis and Haemostasis

Volumn 84, Issue 2, 2000, Pages 228-236

  Gris, Jean Christophe ^a,b,c   Quéré, Isabelle ^c,d   Sanmarco, Marielle ^e   Boutiere, Brigitte ^e   Mercier, Eric ^b   Amiral, Jean ^f   Hubert, Anne Michèle ^e   Ripart Neveu, Sylvie ^b   Hoffet, Méderic ^b   Tailland, Marie Laure ^b   Rousseau, Olivier ^b   Monpeyroux, Françoise ^b   Dauzat, Michel ^c   Sampol, José ^e   Daures, Jean Pierre ^b   Berlan, Jacques ^a   Marès, Pierre ^b  

^a UNIV MONTPELLIER   (France)

^b NÎMES UNIVERSITY HOSPITAL   (France)

^c EA MENRT Dynamique des I   (France)

^d MONTPELLIER UNIVERSITY HOSPITAL   (France)

^e HÔPITAL DE LA CONCEPTION   (France)

^f Serbio   (France)

Author keywords

Annexin V; Antiphospholipid antibodies; Foetal loss; Phosphatidylethanolamine; 2 glycoprotein I

Indexed keywords

ACETYLSALICYLIC ACID; BETA2 GLYCOPROTEIN 1; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; LIPOCORTIN 5; LUPUS ANTICOAGULANT; PHOSPHATIDYLETHANOLAMINE; PHOSPHOLIPID ANTIBODY;

ADULT; AGE; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; PARITY; PRIORITY JOURNAL; RECURRENT ABORTION; RISK FACTOR;

EID: 0033858679     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1614001     Document Type: Article

References (39)

1. McNeil HP, Simpson RJ, Chesterman CN, Krilis SA. Antiphospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: b2-glycoprotein I (apolipoprotein H). Proc Natl Acad Sci USA 1990; 87: 4120-4.
2. Galli M, Comfurius P, Maassen C, Hemker HC, Baets MH, van Breda-Vriesman PJC, Barbui T, Zwall RFA, Bevers EM. Anticardiolipin antibodies directed not to cardiolipin but to a plasma protein cofactor. Lancet 1990; 335: 1544-7.
3. Fleck RA, Rapaport SI, Rao LVM. Anti-prothrombin antibodies and the lupus anticoagulant. Blood 1988; 72: 512-9.
4. Bevers AM, Galli M, Barbui T, Comfurius P, Zwall RFA. Lupus anticoagulant IgG's (LA) are not directed to phospholipids only, but to a complex of lipid-bound human prothrombin. Thromb Haemost 1991; 66: 629-32.
5. Roubey RAS, Pratt CW, Buyon JP, Winfield JB. Lupus anticoagulant activity of autoimmune antiphospholipid antibodies is dependent upon b2-glycoprotein I. J Clin Invest 1992; 90: 1100-4.
6. Nakamura N, Kuragaki C, Shidara Y, Yamaji K, Wada Y. Antibody to annexin V has anti-phospholipid and lupus anticoagulant activity. Am J Hematol 1995; 49: 347-8.
7. Garcia CO, Kanbour-Shakir A, Tang H, Molina JF, Espinoza LR, Gharavi AE. Induction of experimental antiphospholipid antibody syndrome in PL/J mice following immunization with beta 2 GPI. Am J Reprod Immunol 1997; 37: 118-24.
8. Chamley LW, Duncalf AM, Mitchell MD, Johnson PM. Action of anticardiolipin and antibodies to b2-glycoprotein-I on trophoblast proliferation as a mechanism for fetal death. Lancet 1998; 352: 1037-8.
9. Cabral AR, Amigo MC, Cabiedes J, Alarcon-Segovia D. The antiphospholipid/cofactor syndromes: a primary variant with antibodies to b2-glycoprotein-I but no antibodies detectable in standard antiphospholipid assays. Am J Med 1996; 101: 472-81.
10. Gris JC, Quéré I, Montpeyroux F, Mercier E, Ripart-Neveu S, Tailland ML, Hoffet M, Berlan J, Daurès JP, Marès P. Case-control study of the frequency of thrombophilic disorders in couples with late foetal loss and non thrombotic antecedent - The Nîmes Obstetricians and Haematologists study 5 (NOHA5). Thromb Haemost 1999; 81: 891-99.
11. Constant G, Gouault-Heilmann M, Martinolli JL. Heparin inactivation during blood storage. Its prevention by blood collection in citric acid, theophylline, adenosine, dipyridamol - CTAD mixture. Thromb Res 1983; 31: 365-74.
12. Brandt JT, Triplett DA, Alving B, Scharrer I. Criteria for the diagnosis of lupus anticoagulants: an update. Thromb Haemost 1995; 74: 1185-90.
13. Brandt JT, Barna LK, Triplett DA. Laboratory identification of lupus anticoagulants: results of the second international workshop for identification of lupus anticoagulants. Thromb Haemost 1995; 74: 1597-603.
14. Gris JC, Ripart-Neveu S, Maugard C, Tailland ML, Brun S, Courtieu C, Biron C, Hoffet M, Hédon B, Marès P. Prospective evaluation of the prevalence of haemostasis abnormalities in unexplained primary early recurrent miscarriages. Thromb Haemost 1997; 77: 1096-103.
15. Reber G, Arvieux J, Comby E, Degenne D, de Moerloose P, Sanmarco M, Potron G. Multicenter evaluation of nine commercial kits for the quantitation of anticardiolipin antibodies. Thromb Haemost 1995; 73: 444-52.
16. Amiral J, Minard F, Chambrette B. Development of standardized immunoassays for identification, characterization and quantitation of antiphospholipid antibodies (APA). Biol Clin Hematol 1991; 13: 81-8.
17. Amiral J, Larrivaz I, Cluzeau D, Adam M. Standardization of immunoassays for antiphospholipid antibodies with β2-GPI and role of other phospholipid cofactors. Haemostasis 1994; 24: 191-203.
18. Horbach DA, van Oort E, Templeman MJ, Derksen RHWM, de Groot PG. The prevalence of a non-phospholipid-binding form of β2-glycoprotein I in human plasma. Thromb Haemostas 1998; 80: 791-7.
19. Bezaud A, Guillin MC, Olmeda F, Quintina M, Gomez G. Prothrombin Madrid: a new familial abnormality of prothrombin. Thromb Res 1979; 16: 47-58.
20. Romisch J, Heimburger N. Purification and characterization of six annexins from human plasma. Biol Chem Hoppe Seyler 1990; 371: 383-8.
21. Berard M, Boffa MC, Karmochkine M, Aillaud MF, Juhan-Vague I, Frances C, Cacoub P, Piette JC, Harle JR. Plasma reactivity to hexagonal II phase phosphatidylethanolamine is more frequently associated with lupus anticoagulant than with anti-phosphatidylethanolamine antibodies. J Lab Clin Med 1993; 122: 601-5.
22. Molo MW, Kelly M, Balos R, Mullaney K, Radwanska E. Incidence of fetal loss in patients after detection of fetal heart activity with early trans-vaginal ultrasound. J Reprod Med 1993; 38: 804-6.
23. Makikallio K, Tekay A, Jouppila P. Yolk sac and umbilicoplacental hemodynamics during early human embryonic development. Ultrasound Obstet Gynecol 1999; 14: 175-9.
24. Ogasawara M, Sasa H, Katano K, Aoyama T, Aoki K, Suzumori K. Recurrent abortion and moderate or strong antiphospholipid antibody production. Int J Gynaecol Obstet 1998; 62: 183-8.
25. Rai R, Cohne H, Dave M, Regan L. Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriages associated with phospholipid antibodies. Br Med J 1997; 314: 253-7.
26. Sugi T, Katsunuma J, Izumi SI, McIntyre J, Makino T. Prevalence and heterogeneity of antiphosphatidylethanolamine antibodies in patients with recurrent early pregnancy losses. Fertil Steril 1999; 71: 1060-5.
27. Karmochkine M, Berard M, Piette JC, Cacoub P, Aillaud MF, Harle JR, Godeau P, Boffa MC, Harle JR. Antiphosphatidylethanolamine antibodies in systemic lupus erythematosus. Lupus 1993; 2: 420.
28. Vlachoyiannopoulos PG, Beigdeber G, Dueymes M, Youinou P, Hunt JE, Krilis SA, Moutsopoulos HM. Antibodies to phosphatidylethanolamine in antiphospholipid syndrome and systemic lupus erythematosus: their correlation with anticardiolipin antibodies and beta 2 glycoprotein-1 plasma levels. Autoimmunity 1993; 16: 245-9.
29. Sugi T, McIntyre JA. Autoantibodies to phosphatidylethanolamine (PE) recognize a kininogen-PE complex. Blood 1995; 86: 3083-9.
30. Boffa MC, Berard M, Sigi T, McIntyre JA. Antiphosphatidylethanolamine antibodies as the only antiphospholipid antibodies detected by ELISA. II. Kininogen reactivity. J Rheumatol 1996; 23: 1375-9.
31. Horic S, Ishii H, Hara H, Kazama M. Enhancement of thrombin-thrombomodulin-catalysed protein C activation by phosphatidylethanolamine containing unsaturated fatty acids: possible physiological significance of phosphatidylethanolamine in anticoagulant activity of thrombomodulin. Biochem J 1994; 301: 683-91.
32. Neuenschwander PF, Bianco-Fisher E, Rezaie AR, Morrissey JH. Phosphatidylethanolamine augments factor VIIa-tissue factor activity: enhancement of sensivity to phosphatidylserine. Biochemistry 1995; 34: 13988-93.
33. Aoki K, Dudkiewicz AB, Matsuura E, Novotny M, Kaberlein G, Gleicher N. Clinical significance of β2-glycoprotein-dependent anticardiolipin antibodies in the reproductive autoimmune failure syndrome: correlation with conventional antiphospholipid antibody detection systems. J Obstet Gynecol 1995; 172: 926-31.
34. Katano K, Aoki A, Sasa H, Ogasawara M, Matsuura E, Yagami Y. Beta 2-glycoprotein I-dependent anticardiolipin antibodies as a predictor of adverse pregnancy outcomes in healthy pregnant women. Hum Reprod 1996; 11: 509-12.
35. Matsuda J, Gotoh M, Saitoh N, Gohchi K, Tsukamoto M, Yamamoto T. Anti-annexin antibody in the sera of patients with habitual fetal loss or preeclampsia. Thromb Res 1994; 75: 105-6.
36. Kaburaki J, Kuwana M, Yamamoto M, Kawai S, Ikeda Y. Clinical significance of anti-annexin V antibodies in patients with systemic lupus erythematosus. Am J Hematol 1997; 54: 209-13.
37. Schild H, Rtzschke O, Kalbacher H, Rammensee HG. Limit of T cell tolerance to self proteins by peptide presentation. Science 1990; 247: 1587-9.
38. Rand JH, Wu XX, Andree HAM, Lockwood CJ, Guller S, Scher J, Harpel PC. Pregnancy loss in the antiphospholipid-antibody syndrome - a possible thrombogenic mechanism. N Engl J Med 1997; 337: 154-60.
39. Wang X, Campos B, Kaetzel MA, Dedman JR. Annexin V is critical in the maintenance of murine placental integrity. Am J Obstet Gynecol 1999; 180: 1008-16.